CAS 63590-64-7
:Terazosin
Description:
Terazosin is a pharmaceutical compound primarily used as an alpha-1 adrenergic antagonist, commonly prescribed for the treatment of hypertension and benign prostatic hyperplasia (BPH). It works by relaxing blood vessels and smooth muscle in the prostate, thereby improving urine flow and reducing blood pressure. Terazosin is characterized by its chemical formula, which includes a piperazine ring, contributing to its pharmacological activity. The substance is typically administered orally and is known for its relatively long half-life, allowing for once-daily dosing. In terms of solubility, terazosin is moderately soluble in water and more soluble in organic solvents, which influences its formulation in various dosage forms. Common side effects may include dizziness, fatigue, and orthostatic hypotension, particularly upon initiation of therapy. As with many medications, monitoring is essential to manage potential interactions and ensure patient safety. Overall, terazosin exemplifies a well-studied therapeutic agent with specific applications in managing cardiovascular and urological conditions.
Formula:C19H25N5O4
InChI:InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)
InChI key:InChIKey=VCKUSRYTPJJLNI-UHFFFAOYSA-N
SMILES:NC=1C2=C(N=C(N1)N3CCN(C(=O)C4CCCO4)CC3)C=C(OC)C(OC)=C2
Synonyms:- Terazosina
- Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-
- [4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)methanone
- UNII-8L5014XET7
- Terazosin [INN:BAN]
- Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-
- Terazosin
- Terazosinum
- [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone chloride dihydrate
- Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-
- 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
Terazosin Hydrochloride Dihydrate
CAS:Formula:C19H25N5O4·HCl·2H2OPurity:>98.0%(HPLC)(N)Color and Shape:White to Almost white powder to crystalMolecular weight:459.931-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine
CAS:Formula:C19H25N5O4Purity:98%Color and Shape:SolidMolecular weight:387.43291-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-{(tetnaphydro-2-furanyl)carbonyl}piperazine
CAS:<p>1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-{(tetnaphydro-2-furanyl)carbonyl}piperazine</p>Purity:98%Molecular weight:387.44g/molTerazosin
CAS:<p>Terazosin: oral α1-blocker, relaxes blood vessels, treats BPH and hypertension.</p>Formula:C19H25N5O4Color and Shape:SolidMolecular weight:387.43Terazosin Hydrochloride
CAS:Controlled Product<p>Applications An α-1-adrenergicblocker related to prazosin.<br>References Patterson, S.E., et al.: J. Chromatog., 311, 206 (1984), Fort, F.L., et al.: Drug Chem. Toxicol., 7, 435 (1984), Lepor, H., et al.: J. Urol., 148, 1467 (1992),<br></p>Formula:C19H25N5O4·HClColor and Shape:NeatMolecular weight:423.891-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine hydrochloride
CAS:<p>Terazosin HCL dehydrate is an inhibitor of alpha-1 adrenergic receptors. This results in vasodilation followed by a reduction in urethral resistance, venous return to the heart and peripheral vascular resistance. In particular Terazosin HCL hydrate’s ability to recover urine flow and alleviate symptoms in patients with benign prostatic hyperplasia is of benefit to the therapeutic and clinical industries.</p>Formula:C19H26ClN5O4Purity:Min. 95%Molecular weight:423.89 g/mol
![1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine hydrochlori…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F3D%2Fthumb%2FFA28036.jpg&w=3840&q=75)
